Next Article in Journal
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors
Previous Article in Journal
Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 13
Issue 16
10.3390/cancers13164024
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2020, 12(11), 3426.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426

by
Ching-Fu Weng
1,2,
Chi-Jung Huang
3,4,5,
Shih-Hung Huang
6,
Mei-Hsuan Wu
7,
Ailun Heather Tseng
8,
Yung-Chuan Sung
9,
Henry Hsin-Chung Lee
5,10,11,* and
Thai-Yen Ling
2,*
1
Division of Pulmonary Medicine, Department of Internal Medicine, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan
2
Department and Graduate Institute of Pharmacology, National Taiwan University, Taipei 100, Taiwan
3
Medical Research Center, Cathay General Hospital, Taipei 106, Taiwan
4
Department of Biochemistry, National Defense Medical Center, Taipei 114, Taiwan
5
School of Medicine, Fu Jen Catholic University, New Taipei 242, Taiwan
6
Division of Pathology, Cathay General Hospital, Taipei 106, Taiwan
7
Teaching and Research Center, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan
8
Department of Biomedical Sciences and Engineering, National Central University, Taoyuan 320, Taiwan
9
Division of Hematology/Oncology, Department of Internal Medicine, Cathay General Hospital, Taipei 106, Taiwan
10
Department of Surgery, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan
11
Graduate Institute of Translational and Interdisciplinary Medicine, College of Health Sciences and Technology, National Central University, Taoyuan 320, Taiwan
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
Cancers 2021, 13(16), 4024; https://doi.org/10.3390/cancers13164024
Submission received: 22 December 2020 / Accepted: 23 June 2021 / Published: 10 August 2021
(This article belongs to the Section Cancer Pathophysiology)
Browse Figures
Versions Notes
The authors would like to make a correction to their published paper [1].
There was a mistake in the original version of the article in Figures 1 and 2. We found that Figures 1 and 2 were misplaced in the article.
They should be replaced with the following Figure 1 and Figure 2:
Cancers 13 04024 g001 550
Figure 1. Selection criteria for the subjects.
Figure 1. Selection criteria for the subjects.
Cancers 13 04024 g001
Cancers 13 04024 g002 550
Figure 2. Histological patterns of lung adenocarcinoma. Representative hematoxylin and eosin-stained biopsy specimens: (A) lepidic-predominant pattern; (B) acinar-predominant pattern; (C) papillary-predominant pattern; (D) solid-predominant pattern; and (E) micropapillary-predominant pattern.
Figure 2. Histological patterns of lung adenocarcinoma. Representative hematoxylin and eosin-stained biopsy specimens: (A) lepidic-predominant pattern; (B) acinar-predominant pattern; (C) papillary-predominant pattern; (D) solid-predominant pattern; and (E) micropapillary-predominant pattern.
Cancers 13 04024 g002
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Weng, C.-F.; Huang, C.-J.; Huang, S.-H.; Wu, M.-H.; Tseng, A.H.; Sung, Y.-C.; Lee, H.H.-C.; Ling, T.-Y. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Weng, C.-F.; Huang, C.-J.; Huang, S.-H.; Wu, M.-H.; Tseng, A.H.; Sung, Y.-C.; Lee, H.H.-C.; Ling, T.-Y. Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426. Cancers 2021, 13, 4024. https://doi.org/10.3390/cancers13164024

AMA Style

Weng C-F, Huang C-J, Huang S-H, Wu M-H, Tseng AH, Sung Y-C, Lee HH-C, Ling T-Y. Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426. Cancers. 2021; 13(16):4024. https://doi.org/10.3390/cancers13164024

Chicago/Turabian Style

Weng, Ching-Fu, Chi-Jung Huang, Shih-Hung Huang, Mei-Hsuan Wu, Ailun Heather Tseng, Yung-Chuan Sung, Henry Hsin-Chung Lee, and Thai-Yen Ling. 2021. "Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426" Cancers 13, no. 16: 4024. https://doi.org/10.3390/cancers13164024

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop